- Published on
UVEITIS AND RETINITIS, or CHORIORETINITIS
ESSENTIALS DESCRIPTION
Any inflammation of the choroid, ciliary body, and iris, which are located between the outer (sclera and cornea) and inner (retina) coats of the eye, is referred to as uveitis.
• There are several types of uveitis:
- Anterior (limited to the anterior chamber and iris)
as ciliary body involvement or iritis, as well as
as iridocyclitis in this instance.
In the interim (should the inflammatory process emerge in the
pars planitis, or peripheral retina
In the event that the inflammatory process develops in the
vitreous and choroid, whether or not they are involved
of the retina
Panuveitis (should the infection disregard any
anatomical limits inside the eye
• Despite not being a component of the uvea, the retina frequently becomes
either directly (retinitis) or indirectly (chorioretinitis) involved in inflammatory eye conditions. Neurotropic organisms like Toxoplasma gondii and herpes viruses are particularly prone to affecting the retina.
• Acute, recurring, and chronic uveitis can be distinguished based on the temporal pattern of ocular involvement; this differentiation is often useful in establishing a precise diagnosis.
The study of epidemiology
The prevalence
• It is estimated that there are 15 to 50 instances of uveitis per 100,000 people each year.
• Up to 10% of all blindness cases in the US are caused by infectious and noninfectious uveitis.
• The majority of uveitis is anterior uveitis, which includes iritis and iridocyclitis.
• In one-third to one-fifth of cases, idiopathic uveitis, no etiologic diagnosis can be made.
• Based on population-based studies, the distribution of uveitis by anatomic site is as follows:
- Front: 73%
Posterior: 22%
Panuveitis: 5%; Intermediate: 1%
• The choroid frequently serves as a trap for blood-borne infections because of its enormous blood flow and architecture. Common choroidal/retinal lesions that also invade the vitreous (endogenous fungal)
Approximately 1% to 2% of patients with invasive Candida species or candidemia develop endophthalmitis. infections.
The frequency
According to estimates, there are roughly 115 instances of infected and noninfectious uveitis for every 100,000 people in the United States. Prevalence figures vary from 75 to 700 instances per 100,000 people worldwide, with poorer nations providing the highest estimates. The length of the study has an impact on prevalence estimates since the longer a group is investigated, the more likely it is that cases of recurrent uveitis will become active.
RISK ELEMENTS
• In patients with AIDS or HIV-unrelated immunosuppression, a drop in the CD4+ T-lymphocyte count below 50 cells/μL is a substantial risk factor for CMV retinitis.
• AIDS is also a risk factor for progressive outer retinal necrosis (PORN), a typical manifestation of necrotizing retinitis linked to VZV.
Genetics
• Despite having a modest positive predictive value, HLA-typing has been widely utilized to diagnose patients with noninfectious uveitis. Therefore, HLA-typing should only be used to validate a particular clinical suspicion.
• When seronegative spondyloarthropathies are present, anterior uveitis is linked to HLA-B27.
• 85–95% of people with Birdshot's chorioretinopathy, a prevalent condition that causes posterior uveitis, have HLA-A29.
• HLA-B51 is around nine times more common in people with Adamantiades-Behcet's illness than in the general population, while HLA-DR2 and HLA-DR15 have been linked to intermediate uveitis.
OVERALL PREVENTION
To the extent that the related illness or infection can be avoided, so can ocular inflammation. For instance, preventing pregnant women with weakened immune systems from consuming raw or undercooked meat and potentially soil-contaminated fruits and vegetables can reduce the incidence of vertically transmitted ocular toxoplasmosis.
Pathophysiology
• Uveitis is typically brought on by an immunological response.
This could be an autoimmune reaction to several uveitogenic ocular antigens (such as Retinal S-Antigen) or a host's reaction to invasive pathogens.
• Autoimmune conditions such rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, and seronegative spondyloarthropathies are often diagnosed in conjunction with uveitis. In certain situations, immune system components that interact with loci in the retina, ciliary body, iris epithelium, or retinal pigmented epithelium may cause uveitis.
Ethiology
Bacterial infections are among the infectious causes of uveitis.
Non-standard mycobacteria
Bejel
Brucellosis
Leptospirosis with cat-scratch disease (Bartonella henselae)
Leprosy
Whipple's disease, tuberculosis, syphilis, nocardiosis, and Lyme illness
– Spreading
CMV, or cytomegalovirus
EBV, or Epstein-Barr virus
HSV, or herpes simplex virus
VZV, or varicella zoster virus
Mumps, human T cell leukemia virus, and human immunodeficiency virus (HIV)
Rubella
Rubeola
The West Nile virus
Fungi-induced Aspergillosis
Coccidiomycosis, Cryptococcosis, Candidiasis, and Blastomycosis
Presumed Ocular Histoplasmosis Syndrome (POHS): Histoplasmosis
Boydii pseudoallescheria
The parasitic disease sporotrichosis
Acanthamoeba (causes intraocular inflammation and keratitis)
Pneumocystis carinii, Onchocerciasis, Cysticercosis, and Toxocariasis
In western countries, toxoplasmosis is the most frequent cause of posterior uveitis.
• One prominent cause of chorioretinitis is CMV retinitis, which is becoming less common in the HAART era and is typically linked to advanced HIV infection. Up to 30% of AIDS patients would acquire CMV retinitis prior to the availability of HAART.
• In healthy hosts, toxoplasmosis is a surprisingly frequent cause of uveitis. It is thought to be a congenitally acquired infection reactivating. Serology-supported typical chorioretinal lesions are used to make the diagnosis. In the healthy US population, serologic evidence of prior toxoplasmosis infection is very prevalent.
• A small percentage of uveitis patients have syphilis. It can show up as retinal vasculitis or chorioretinitis, which are examples of posterior uveitis. Because of its potential for treatment, syphilis must be identified.
• In the western world, tuberculosis is a rare cause of uveitis. A granulomatous look of the ocular inflammation, immunosuppression, recent immigration from endemic areas, cachexia, homelessness, and active tuberculosis elsewhere in the body should all be taken into consideration.
The link between cat-scratch illness (B. henselae) and uveitis (neuroretinitis) is becoming more widely acknowledged.
•
• Keratouveitis, an inflammation, can be brought on by HSV and VZV.
of the cornea as well as mostly anterior uveitis. Acute retinal necrosis (ARN), a necrotizing retinitis, can also be brought on by either HSV or VZV.
• Histoplasma capsulatum can enter the bloodstream and go to the choroid after being inhaled in endemic regions (the Ohio–Mississippi River Valley). Ocular symptoms including peripapillary atrophy, tiny, round fundus lesions with little to no inflammation, and the early-life macular choroidal neovascular membranes that make up the POHS have all been connected to exposure.
• When making an etiologic diagnosis, geographic factors are important. For instance, leptospirosis and tuberculosis are significant factors to take into account in developing nations when uveitis occurs, as these conditions are uncommon in western nations.
COMMON CONNECTED CIRCUMSTANCES
Sarcoidosis, systemic lupus erythematosus, seronegative spondyloarthropathies, and other connective tissue diseases often appear with or are linked to uveitis.
History of Diagnosis
• Light sensitivity (photophobia) and dull periorbital pain, with or without reduced vision, are common symptoms of anterior uveitis. Similar to juvenile idiopathic arthritis, uveitis in children can occur without obvious symptoms, yet it can have a serious impact on their vision.
Similar symptoms, such as vitreous opacities (floaters) and typically impaired vision, are present in posterior uveitis.
MEDICAL EXAMINATION
• Slit-lamp examination shows inflammatory cells in the anterior chamber, and redness of the eye (conjunctival injection) is typically evident in anterior uveitis.
•
•
The diagnosis of herpetic keratouveitis can be made with the help of cutaneous vesicles, distinctive corneal alterations, decreased corneal sensitivity, increased intraocular pressure, and iris atrophy.
Inflammatory cells or even larger cell aggregates are present in posterior and intermediate uveitis.
in the vitreous cavity (snowballs).
· People with impaired immune systems frequently don't constitute
an inflammatory reaction, even when there is substantial
involvement of the eyes.
• Typically, Toxoplasma chorioretinitis manifests as big,
Adjacent to old chorioretinal scars are smooth, yellow-white retinal lesions accompanied by vitreous inflammation. Multiple, bilateral lesions linked to encephalitis can occur in immunocompromised persons.
• Because of the patient's weakened immune system, CMV retinitis manifests as hemorrhagic necrotizing retinitis with minimal inflammation.
• In immunocompetent patients, HSV, VZV, and infrequently CMV can result in acute retinal necrosis, a widespread unilateral or bilateral necrotizing nonhemorrhagic retinitis. It is frequently linked to trigeminal zoster or orolabial HSV. Widespread, light gray peripheral lesions are found on ophthalmologic examination. If left untreated, the lesions spread quickly.
PORN, a subtype of necrotizing rapidly progressive retinitis, primarily affects patients with impaired immune systems. VZV is the most often isolated viral pathogen.
• Focused white choroidal lesions that extend into the retina are the hallmark of Candida chorioretinitis. The phrase "endogenous fungal endophthalmitis" is more acceptable if the vitreous is affected (see Chapter
"Endophthalmitis."
• B was once believed to be idiopathic. Henselae is a cause.
of cat scratch disease-related neuroretinitis. Swelling of the optic disk, peripapillary and macular hard exudates (macular star), and frequently vitreous cells are the hallmarks of neuroretinitis.
• Several yellow-white choroidal nodules up to half the disk diameter in size and with hazy borders are visible in uveitis owing to tuberculosis. Additionally, patients may experience anterior granulomatous uveitis concurrently.
• If a tick bite history is obtained, a range of ocular symptoms, such as intermediate uveitis, conjunctivitis, keratitis, double vision due to cranial nerve involvement, or disc edema due to optic neuritis, should be anticipated.
Tests for Diagnosis and Interpretation
Lab
First laboratory testing
• Slit-lamp examination is necessary to detect inflammatory cells floating in the aqueous humor and/or deposited on the corneal endothelium (keratic precipitates) in order to diagnose anterior uveitis (iritis and iridocyclitis).
• Involvement of the posterior (intermediate)
The best way to document uveitis is with a dilated fundus.
analysis.
• Because a thorough laboratory analysis may not be conclusive
Unilateral, nongranulomatous, nonrecurrent cases (first episode) with just anterior involvement should be treated symptomatically with topical prednisolone and cycloplegics without additional workup in as many as one-third of cases, even at tertiary uveitis referral facilities.
• The following procedures should be performed on patients with posterior uveitis:
A full blood count that includes differential
Syphilis serology (FTA-ABS and VDRL) - Toxoplasma antibody titer
Assessment for tuberculosis (chest radiograph and PPD skin test)
• A thorough history, physical examination, and consideration of particular ocular characteristics should direct any additional diagnostic workup.
• A considerable percentage of patients with tertiary syphilis may have negative VDRL results. In addition, pregnancy, intravenous drug misuse, TB, rickettsial infection, nonsyphilis treponemal infection, and endocarditis have all been linked to false positive nontreponemal screening tests (VDRL& RPR). As a result, for accurate interpretation, a reactive nontreponemal test must always be verified by a certain treponemal test (FTA-ABS).
• Primary toxoplasmosis can be diagnosed with IgM-positive and IgG-negative serology; toxoplasmosis is unlikely to be diagnosed if both IgM and IgG are negative. In order to diagnose a reactivation of ocular toxoplasmosis, toxoplasma IgG titers show a four-fold increase that peaks 6–8 weeks after infection and decreases over the next two years, but they are detectable for life.
• Because serology is not always accurate, the diagnosis of CMV chorioretinitis in susceptible patients is established on clinical grounds.
In situations of necrotizing retinitis, which is sometimes aggravated by spontaneous retinal detachments, a vitreous biopsy submitted for cytology or exposed to PCR for viral infections (CMV, HSV, and VZV) can be beneficial. However, the procedure is not risk-free.
• A number of conditions (such as toxocariasis, B. henselae, brucellosis, leptospirosis, HSV, CMV, VZV, EBV, HIV, HTLV, Lyme disease, histoplasmosis, etc.) can benefit from serum antibody testing.
The examination of some individuals may be aided by lumbar puncture, neuroimaging, skin lesion biopsy, ACE levels, chest X-rays, and colonoscopy (e.g., toxoplasmosis, inflammatory bowel disease, neurosyphilis, or sarcoidosis).
Follow-up and Particular Points to Remember
Regular follow-up exams are necessary until a diagnosis is made or a treatment response is recorded.
Imagining
• Chest CT scans or X-rays can offer diagnostic hints for many conditions (tumor, histoplasmosis, sarcoidosis, tuberculosis, etc.).
• Among other conditions, rheumatoid arthritis, lupus, gonorrhea, and seronegative spondyloarthropathies linked to HLA-B27 can benefit from joint films.
• To confirm probable sarcoidosis, gallium scans are used.
Diagnostic Techniques and Other
Under sterile conditions, a vitreous tap can be carried out, and the samples ought to be sent for cytology and PCR to check for certain pathogens (see above).
Pathological Results
A diagnostic biopsy is rarely required with today's diagnostic methods, and it may be limited to cases of necrotizing retinitis (ARN) that are worsened by retinal detachment, in which case tissue is taken during surgical repair. Intranuclear in the early stages
Characteristic are inclusions created by herpesvirus particles that are multiplying.
DISTINCTIVE DIAGNOSIS
As previously discussed under "Etiology," there is a wide range of differential diagnoses between chorioretinitis and ocular inflammation (uveitis).
MEDICATION FOR TREATMENT
First Phrase
• The goal of treating anterior uveitis with topical steroids (prednisolone acetate 1%) is to minimize scarring and inflammation. By using topical cycloplegic medicines (cyclopentolate 1%) to treat mydriasis, discomfort and photophobia are decreased and synechiae development is inhibited.
• When infectious uveitis occurs, etiologic therapy is required. After starting antibiotic treatment, topical or systemic steroids might be administered to reduce the inflammatory response.
• Immunocompetent patients with ocular toxoplasmosis do not require therapy unless they have lesions close to the macula or optic nerve that endanger their vision. Pyrimethamine (200 mg p.o. loading dosage and then 25 mg p.o. per day) combined with folinic acid (10 mg p.o. twice weekly) and sulfadiazine (2 g p.o. loading dose and then 1 g p.o. q.i.d.) or clindamycin (150–450 mg p.o. q.i.d.) is used in these situations.
suggested. It is possible to add prednisone (0.5–1 mg/kg p.o. each day) 24 hours after starting the antibiotic treatment.
• Some authors recommend CSF testing and treatment with crystalline penicillin G (2–4 million units i.v. every 4 hours) for 10–14 days, followed by benzathine penicillin (2.4 million units i.m. weekly) for 3 weeks, because they believe that any type of ocular inflammation (anterior, intermediate, posterior uveitis, retinitis, or optic neuritis) in syphilis is neurosyphilis. Others think that neurosyphilis is limited to involvement of the retina or optic nerve. In order to track therapy response, CSF should be collected and sent for VDRL. According to current CDC guidelines, if CSF VDRL is positive, neurosyphilis is present regardless of ocular involvement. If high protein or white cell counts are seen in the CSF of specific patients, the diagnosis is deemed likely. HIV patients with syphilis frequently experience treatment failures, but it should be emphasized that HIV patients may still exhibit CSF abnormalities (see pertinent chapters).
• A two-week treatment trial of isoniazid (300 mg p.o. per day) and pyridoxine (10 mg p.o. per day) may be administered to individuals with suspected TB-related uveitis.
• Starting HAART is the most crucial step in treating CMV retinitis in order to achieve immunological
recuperation, which could take many weeks to accomplish. CMV-specific therapy is required during that time to prevent vision loss and slow the progression of necrotizing retinitis.
• Ganciclovir, foscarnet, and cidofovir are the three antiviral medications that work well for treating CMV retinitis. Ganciclovir's intravenous induction dose is 5 mg/kg. b.i.d. for 14–21 days; 5 mg/kg i.v. is the maintenance dosage. daily, seven days a week, or 6 mg/kg intravenously. five days a week, every day. Foscarnet's intravenous induction dose is 90 mg/kg. b.i.d. for 14–21 days; 90–120 mg/kg i.v. is the maintenance dose. every day. Cidofovir's intravenous induction dose is 5 mg/kg. per week for two weeks; the maintenance dose is administered at two-week intervals and is the same. The oral prodrug valganciclovir, which is administered at doses of 900 mg p.o., just became accessible and has a bioavailability comparable to that of intravenous ganciclovir. b.i.d. during the first 21 days of induction therapy; valganciclovir dosage is lowered to 900 mg p.o. after this time. daily for the purpose of maintenance therapy. Patients who continue to be immunosuppressed should continue their therapy.
• After the CD4+ count reaches 100–150 cells/μL for a prolonged duration of 3–6 months and the CMV retinitis stays dormant, anti-CMV treatment can be stopped; nevertheless, ongoing surveillance for disease reactivation is advised.
• Treatment options for relapse or resistant CMV retinitis include
intraocular injections (cidofovir [administered less regularly], ganciclovir, foscarnet, and fomivirsen) or with the
sustained-release ganciclovir implant (Vitrasert®, Bausch & Lomb, San Dimas, CA) that releases medication for up to eight months after being placed through the pars plana. Most specialists believe that the ganciclovir implant is the best option for people with immediately sight-threatening disease because it is more successful than intravenous ganciclovir in treating CMV retinitis. However, this method necessitates intraocular surgery, which could have negative consequences. A brand-new anti-sense oligonucleotide called fomivirsen is injected into the eye in 0.5 mL doses on days 1 and 15 and then monthly after that (330 μg/0.5 mL).
• Controlling the spread of the CMV infection to other organs or to the other eye is not possible with local therapy.
• For ten to fourteen days, ARN is treated with intravenous acyclovir (1500 mg/m2 of body surface area in three divided doses). To avoid second eye involvement, treatment is continued for a total of 6 weeks with oral valganciclovir (1 g p.o. t.i.d.). To avoid retinal detachment, preventative barrier laser photocoagulation should be taken into consideration.
• In six weeks, cat scratch disease goes away on its own. One possible treatment option is azithromycin (500 mg p.o. q.i.d., followed by four doses of 250 mg p.o. every day). Although the long-term outlook is favorable, some people may experience hardship.
from a minor optic neuropathy that was caused by an infection.
• In POHS, systemic antifungal drugs are not required. The goals of intravitreal anti-VEGF therapy, photocoagulation, and corticosteroids are to lessen the size and effects of the macular choroidal
neovascularization.
Line Two
• It has been demonstrated that trimethoprim + sulfamethoxazole (160/800 mg p.o. b.i.d.) is an effective treatment regimen for CNS toxoplasmosis in AIDS patients. It can also be used to treat ocular toxoplasmosis in patients who cannot tolerate pyrimethamine.
• Aspirin dosages of 125–625 mg PO daily may be taken into consideration in ARN.
• When ganciclovir, foscarnet, and cidofovir are not effective in treating CMV retinitis, fomivirsen is an alternative. In the US, it is no longer accessible.
ADDITIONAL MEDICATION
Referral Issues
The treating ophthalmologist, who can assess the response to treatment, is frequently involved in management choices.
OTHER PROCEDURES AND SURGERY
Only the treatment of problems like cataract, retinal detachment, and ocular glaucoma involves surgery.
Considering the patient
First Stabilization
The majority of uveitis patients are treated as outpatients.
Requirements for Admission
Only patients with extensive ocular involvement who are monocular, socially excluded, or systemically unwell are hospitalized.
PERMANENT CARE
SUMMARY RECOMMENDATIONS
Follow-up is customized.
Monitoring of Patients
In order to control ocular inflammation, some patients with recurrent uveitis require continuous immune modulation, while others require lifelong monitoring. Even infectious uveitis, such as that caused by toxoplasmosis or herpetic keratouveitis, can reactivate ocular inflammation.
A DIET
There are no particular restrictions that are relevant to the sight.
Education of Patients
Particularly in cases of recurrent uveitis, patient education regarding early detection of signs and symptoms of ocular inflammation is crucial because timely treatment is linked to a quicker recovery and
fewer difficulties.
PROGNOSIS
The particular ailment producing chorioretinitis or uveitis determines the prognosis. 79% of patients with ocular toxoplasmosis who are monitored for more than five years will experience recurrences. Of individuals with ocular toxoplasmosis, 24% have been confirmed to have legal blindness in one or both eyes. When compared to conventional anti-CMV therapy alone, HAART has extended the duration of CMV retinitis remission by seven times. Legal blindness has decreased to roughly 6–15% every eye-year in people with CMV retinitis.
DIFFICULTIES
• Long-term use of steroids can contribute to the development of cataracts and glaucoma, which are frequent side effects of chronic ocular inflammation.
• Cystoid macular edema, which alters the normal macular architecture and reduces visual acuity, is another condition that inflammation can induce.
• Up to one-third of patients with CMV retinitis may experience rhegmatogenous retinal detachment. This also holds true for other types of necrotizing retinitis, like PORN and ARN.
ESSENTIALS DESCRIPTION
Any inflammation of the choroid, ciliary body, and iris, which are located between the outer (sclera and cornea) and inner (retina) coats of the eye, is referred to as uveitis.
• There are several types of uveitis:
- Anterior (limited to the anterior chamber and iris)
as ciliary body involvement or iritis, as well as
as iridocyclitis in this instance.
In the interim (should the inflammatory process emerge in the
pars planitis, or peripheral retina
In the event that the inflammatory process develops in the
vitreous and choroid, whether or not they are involved
of the retina
Panuveitis (should the infection disregard any
anatomical limits inside the eye
• Despite not being a component of the uvea, the retina frequently becomes
either directly (retinitis) or indirectly (chorioretinitis) involved in inflammatory eye conditions. Neurotropic organisms like Toxoplasma gondii and herpes viruses are particularly prone to affecting the retina.
• Acute, recurring, and chronic uveitis can be distinguished based on the temporal pattern of ocular involvement; this differentiation is often useful in establishing a precise diagnosis.
The study of epidemiology
The prevalence
• It is estimated that there are 15 to 50 instances of uveitis per 100,000 people each year.
• Up to 10% of all blindness cases in the US are caused by infectious and noninfectious uveitis.
• The majority of uveitis is anterior uveitis, which includes iritis and iridocyclitis.
• In one-third to one-fifth of cases, idiopathic uveitis, no etiologic diagnosis can be made.
• Based on population-based studies, the distribution of uveitis by anatomic site is as follows:
- Front: 73%
Posterior: 22%
Panuveitis: 5%; Intermediate: 1%
• The choroid frequently serves as a trap for blood-borne infections because of its enormous blood flow and architecture. Common choroidal/retinal lesions that also invade the vitreous (endogenous fungal)
Approximately 1% to 2% of patients with invasive Candida species or candidemia develop endophthalmitis. infections.
The frequency
According to estimates, there are roughly 115 instances of infected and noninfectious uveitis for every 100,000 people in the United States. Prevalence figures vary from 75 to 700 instances per 100,000 people worldwide, with poorer nations providing the highest estimates. The length of the study has an impact on prevalence estimates since the longer a group is investigated, the more likely it is that cases of recurrent uveitis will become active.
RISK ELEMENTS
• In patients with AIDS or HIV-unrelated immunosuppression, a drop in the CD4+ T-lymphocyte count below 50 cells/μL is a substantial risk factor for CMV retinitis.
• AIDS is also a risk factor for progressive outer retinal necrosis (PORN), a typical manifestation of necrotizing retinitis linked to VZV.
Genetics
• Despite having a modest positive predictive value, HLA-typing has been widely utilized to diagnose patients with noninfectious uveitis. Therefore, HLA-typing should only be used to validate a particular clinical suspicion.
• When seronegative spondyloarthropathies are present, anterior uveitis is linked to HLA-B27.
• 85–95% of people with Birdshot's chorioretinopathy, a prevalent condition that causes posterior uveitis, have HLA-A29.
• HLA-B51 is around nine times more common in people with Adamantiades-Behcet's illness than in the general population, while HLA-DR2 and HLA-DR15 have been linked to intermediate uveitis.
OVERALL PREVENTION
To the extent that the related illness or infection can be avoided, so can ocular inflammation. For instance, preventing pregnant women with weakened immune systems from consuming raw or undercooked meat and potentially soil-contaminated fruits and vegetables can reduce the incidence of vertically transmitted ocular toxoplasmosis.
Pathophysiology
• Uveitis is typically brought on by an immunological response.
This could be an autoimmune reaction to several uveitogenic ocular antigens (such as Retinal S-Antigen) or a host's reaction to invasive pathogens.
• Autoimmune conditions such rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, and seronegative spondyloarthropathies are often diagnosed in conjunction with uveitis. In certain situations, immune system components that interact with loci in the retina, ciliary body, iris epithelium, or retinal pigmented epithelium may cause uveitis.
Ethiology
Bacterial infections are among the infectious causes of uveitis.
Non-standard mycobacteria
Bejel
Brucellosis
Leptospirosis with cat-scratch disease (Bartonella henselae)
Leprosy
Whipple's disease, tuberculosis, syphilis, nocardiosis, and Lyme illness
– Spreading
CMV, or cytomegalovirus
EBV, or Epstein-Barr virus
HSV, or herpes simplex virus
VZV, or varicella zoster virus
Mumps, human T cell leukemia virus, and human immunodeficiency virus (HIV)
Rubella
Rubeola
The West Nile virus
Fungi-induced Aspergillosis
Coccidiomycosis, Cryptococcosis, Candidiasis, and Blastomycosis
Presumed Ocular Histoplasmosis Syndrome (POHS): Histoplasmosis
Boydii pseudoallescheria
The parasitic disease sporotrichosis
Acanthamoeba (causes intraocular inflammation and keratitis)
Pneumocystis carinii, Onchocerciasis, Cysticercosis, and Toxocariasis
In western countries, toxoplasmosis is the most frequent cause of posterior uveitis.
• One prominent cause of chorioretinitis is CMV retinitis, which is becoming less common in the HAART era and is typically linked to advanced HIV infection. Up to 30% of AIDS patients would acquire CMV retinitis prior to the availability of HAART.
• In healthy hosts, toxoplasmosis is a surprisingly frequent cause of uveitis. It is thought to be a congenitally acquired infection reactivating. Serology-supported typical chorioretinal lesions are used to make the diagnosis. In the healthy US population, serologic evidence of prior toxoplasmosis infection is very prevalent.
• A small percentage of uveitis patients have syphilis. It can show up as retinal vasculitis or chorioretinitis, which are examples of posterior uveitis. Because of its potential for treatment, syphilis must be identified.
• In the western world, tuberculosis is a rare cause of uveitis. A granulomatous look of the ocular inflammation, immunosuppression, recent immigration from endemic areas, cachexia, homelessness, and active tuberculosis elsewhere in the body should all be taken into consideration.
The link between cat-scratch illness (B. henselae) and uveitis (neuroretinitis) is becoming more widely acknowledged.
•
• Keratouveitis, an inflammation, can be brought on by HSV and VZV.
of the cornea as well as mostly anterior uveitis. Acute retinal necrosis (ARN), a necrotizing retinitis, can also be brought on by either HSV or VZV.
• Histoplasma capsulatum can enter the bloodstream and go to the choroid after being inhaled in endemic regions (the Ohio–Mississippi River Valley). Ocular symptoms including peripapillary atrophy, tiny, round fundus lesions with little to no inflammation, and the early-life macular choroidal neovascular membranes that make up the POHS have all been connected to exposure.
• When making an etiologic diagnosis, geographic factors are important. For instance, leptospirosis and tuberculosis are significant factors to take into account in developing nations when uveitis occurs, as these conditions are uncommon in western nations.
COMMON CONNECTED CIRCUMSTANCES
Sarcoidosis, systemic lupus erythematosus, seronegative spondyloarthropathies, and other connective tissue diseases often appear with or are linked to uveitis.
History of Diagnosis
• Light sensitivity (photophobia) and dull periorbital pain, with or without reduced vision, are common symptoms of anterior uveitis. Similar to juvenile idiopathic arthritis, uveitis in children can occur without obvious symptoms, yet it can have a serious impact on their vision.
Similar symptoms, such as vitreous opacities (floaters) and typically impaired vision, are present in posterior uveitis.
MEDICAL EXAMINATION
• Slit-lamp examination shows inflammatory cells in the anterior chamber, and redness of the eye (conjunctival injection) is typically evident in anterior uveitis.
•
•
The diagnosis of herpetic keratouveitis can be made with the help of cutaneous vesicles, distinctive corneal alterations, decreased corneal sensitivity, increased intraocular pressure, and iris atrophy.
Inflammatory cells or even larger cell aggregates are present in posterior and intermediate uveitis.
in the vitreous cavity (snowballs).
· People with impaired immune systems frequently don't constitute
an inflammatory reaction, even when there is substantial
involvement of the eyes.
• Typically, Toxoplasma chorioretinitis manifests as big,
Adjacent to old chorioretinal scars are smooth, yellow-white retinal lesions accompanied by vitreous inflammation. Multiple, bilateral lesions linked to encephalitis can occur in immunocompromised persons.
• Because of the patient's weakened immune system, CMV retinitis manifests as hemorrhagic necrotizing retinitis with minimal inflammation.
• In immunocompetent patients, HSV, VZV, and infrequently CMV can result in acute retinal necrosis, a widespread unilateral or bilateral necrotizing nonhemorrhagic retinitis. It is frequently linked to trigeminal zoster or orolabial HSV. Widespread, light gray peripheral lesions are found on ophthalmologic examination. If left untreated, the lesions spread quickly.
PORN, a subtype of necrotizing rapidly progressive retinitis, primarily affects patients with impaired immune systems. VZV is the most often isolated viral pathogen.
• Focused white choroidal lesions that extend into the retina are the hallmark of Candida chorioretinitis. The phrase "endogenous fungal endophthalmitis" is more acceptable if the vitreous is affected (see Chapter
"Endophthalmitis."
• B was once believed to be idiopathic. Henselae is a cause.
of cat scratch disease-related neuroretinitis. Swelling of the optic disk, peripapillary and macular hard exudates (macular star), and frequently vitreous cells are the hallmarks of neuroretinitis.
• Several yellow-white choroidal nodules up to half the disk diameter in size and with hazy borders are visible in uveitis owing to tuberculosis. Additionally, patients may experience anterior granulomatous uveitis concurrently.
• If a tick bite history is obtained, a range of ocular symptoms, such as intermediate uveitis, conjunctivitis, keratitis, double vision due to cranial nerve involvement, or disc edema due to optic neuritis, should be anticipated.
Tests for Diagnosis and Interpretation
Lab
First laboratory testing
• Slit-lamp examination is necessary to detect inflammatory cells floating in the aqueous humor and/or deposited on the corneal endothelium (keratic precipitates) in order to diagnose anterior uveitis (iritis and iridocyclitis).
• Involvement of the posterior (intermediate)
The best way to document uveitis is with a dilated fundus.
analysis.
• Because a thorough laboratory analysis may not be conclusive
Unilateral, nongranulomatous, nonrecurrent cases (first episode) with just anterior involvement should be treated symptomatically with topical prednisolone and cycloplegics without additional workup in as many as one-third of cases, even at tertiary uveitis referral facilities.
• The following procedures should be performed on patients with posterior uveitis:
A full blood count that includes differential
Syphilis serology (FTA-ABS and VDRL) - Toxoplasma antibody titer
Assessment for tuberculosis (chest radiograph and PPD skin test)
• A thorough history, physical examination, and consideration of particular ocular characteristics should direct any additional diagnostic workup.
• A considerable percentage of patients with tertiary syphilis may have negative VDRL results. In addition, pregnancy, intravenous drug misuse, TB, rickettsial infection, nonsyphilis treponemal infection, and endocarditis have all been linked to false positive nontreponemal screening tests (VDRL& RPR). As a result, for accurate interpretation, a reactive nontreponemal test must always be verified by a certain treponemal test (FTA-ABS).
• Primary toxoplasmosis can be diagnosed with IgM-positive and IgG-negative serology; toxoplasmosis is unlikely to be diagnosed if both IgM and IgG are negative. In order to diagnose a reactivation of ocular toxoplasmosis, toxoplasma IgG titers show a four-fold increase that peaks 6–8 weeks after infection and decreases over the next two years, but they are detectable for life.
• Because serology is not always accurate, the diagnosis of CMV chorioretinitis in susceptible patients is established on clinical grounds.
In situations of necrotizing retinitis, which is sometimes aggravated by spontaneous retinal detachments, a vitreous biopsy submitted for cytology or exposed to PCR for viral infections (CMV, HSV, and VZV) can be beneficial. However, the procedure is not risk-free.
• A number of conditions (such as toxocariasis, B. henselae, brucellosis, leptospirosis, HSV, CMV, VZV, EBV, HIV, HTLV, Lyme disease, histoplasmosis, etc.) can benefit from serum antibody testing.
The examination of some individuals may be aided by lumbar puncture, neuroimaging, skin lesion biopsy, ACE levels, chest X-rays, and colonoscopy (e.g., toxoplasmosis, inflammatory bowel disease, neurosyphilis, or sarcoidosis).
Follow-up and Particular Points to Remember
Regular follow-up exams are necessary until a diagnosis is made or a treatment response is recorded.
Imagining
• Chest CT scans or X-rays can offer diagnostic hints for many conditions (tumor, histoplasmosis, sarcoidosis, tuberculosis, etc.).
• Among other conditions, rheumatoid arthritis, lupus, gonorrhea, and seronegative spondyloarthropathies linked to HLA-B27 can benefit from joint films.
• To confirm probable sarcoidosis, gallium scans are used.
Diagnostic Techniques and Other
Under sterile conditions, a vitreous tap can be carried out, and the samples ought to be sent for cytology and PCR to check for certain pathogens (see above).
Pathological Results
A diagnostic biopsy is rarely required with today's diagnostic methods, and it may be limited to cases of necrotizing retinitis (ARN) that are worsened by retinal detachment, in which case tissue is taken during surgical repair. Intranuclear in the early stages
Characteristic are inclusions created by herpesvirus particles that are multiplying.
DISTINCTIVE DIAGNOSIS
As previously discussed under "Etiology," there is a wide range of differential diagnoses between chorioretinitis and ocular inflammation (uveitis).
MEDICATION FOR TREATMENT
First Phrase
• The goal of treating anterior uveitis with topical steroids (prednisolone acetate 1%) is to minimize scarring and inflammation. By using topical cycloplegic medicines (cyclopentolate 1%) to treat mydriasis, discomfort and photophobia are decreased and synechiae development is inhibited.
• When infectious uveitis occurs, etiologic therapy is required. After starting antibiotic treatment, topical or systemic steroids might be administered to reduce the inflammatory response.
• Immunocompetent patients with ocular toxoplasmosis do not require therapy unless they have lesions close to the macula or optic nerve that endanger their vision. Pyrimethamine (200 mg p.o. loading dosage and then 25 mg p.o. per day) combined with folinic acid (10 mg p.o. twice weekly) and sulfadiazine (2 g p.o. loading dose and then 1 g p.o. q.i.d.) or clindamycin (150–450 mg p.o. q.i.d.) is used in these situations.
suggested. It is possible to add prednisone (0.5–1 mg/kg p.o. each day) 24 hours after starting the antibiotic treatment.
• Some authors recommend CSF testing and treatment with crystalline penicillin G (2–4 million units i.v. every 4 hours) for 10–14 days, followed by benzathine penicillin (2.4 million units i.m. weekly) for 3 weeks, because they believe that any type of ocular inflammation (anterior, intermediate, posterior uveitis, retinitis, or optic neuritis) in syphilis is neurosyphilis. Others think that neurosyphilis is limited to involvement of the retina or optic nerve. In order to track therapy response, CSF should be collected and sent for VDRL. According to current CDC guidelines, if CSF VDRL is positive, neurosyphilis is present regardless of ocular involvement. If high protein or white cell counts are seen in the CSF of specific patients, the diagnosis is deemed likely. HIV patients with syphilis frequently experience treatment failures, but it should be emphasized that HIV patients may still exhibit CSF abnormalities (see pertinent chapters).
• A two-week treatment trial of isoniazid (300 mg p.o. per day) and pyridoxine (10 mg p.o. per day) may be administered to individuals with suspected TB-related uveitis.
• Starting HAART is the most crucial step in treating CMV retinitis in order to achieve immunological
recuperation, which could take many weeks to accomplish. CMV-specific therapy is required during that time to prevent vision loss and slow the progression of necrotizing retinitis.
• Ganciclovir, foscarnet, and cidofovir are the three antiviral medications that work well for treating CMV retinitis. Ganciclovir's intravenous induction dose is 5 mg/kg. b.i.d. for 14–21 days; 5 mg/kg i.v. is the maintenance dosage. daily, seven days a week, or 6 mg/kg intravenously. five days a week, every day. Foscarnet's intravenous induction dose is 90 mg/kg. b.i.d. for 14–21 days; 90–120 mg/kg i.v. is the maintenance dose. every day. Cidofovir's intravenous induction dose is 5 mg/kg. per week for two weeks; the maintenance dose is administered at two-week intervals and is the same. The oral prodrug valganciclovir, which is administered at doses of 900 mg p.o., just became accessible and has a bioavailability comparable to that of intravenous ganciclovir. b.i.d. during the first 21 days of induction therapy; valganciclovir dosage is lowered to 900 mg p.o. after this time. daily for the purpose of maintenance therapy. Patients who continue to be immunosuppressed should continue their therapy.
• After the CD4+ count reaches 100–150 cells/μL for a prolonged duration of 3–6 months and the CMV retinitis stays dormant, anti-CMV treatment can be stopped; nevertheless, ongoing surveillance for disease reactivation is advised.
• Treatment options for relapse or resistant CMV retinitis include
intraocular injections (cidofovir [administered less regularly], ganciclovir, foscarnet, and fomivirsen) or with the
sustained-release ganciclovir implant (Vitrasert®, Bausch & Lomb, San Dimas, CA) that releases medication for up to eight months after being placed through the pars plana. Most specialists believe that the ganciclovir implant is the best option for people with immediately sight-threatening disease because it is more successful than intravenous ganciclovir in treating CMV retinitis. However, this method necessitates intraocular surgery, which could have negative consequences. A brand-new anti-sense oligonucleotide called fomivirsen is injected into the eye in 0.5 mL doses on days 1 and 15 and then monthly after that (330 μg/0.5 mL).
• Controlling the spread of the CMV infection to other organs or to the other eye is not possible with local therapy.
• For ten to fourteen days, ARN is treated with intravenous acyclovir (1500 mg/m2 of body surface area in three divided doses). To avoid second eye involvement, treatment is continued for a total of 6 weeks with oral valganciclovir (1 g p.o. t.i.d.). To avoid retinal detachment, preventative barrier laser photocoagulation should be taken into consideration.
• In six weeks, cat scratch disease goes away on its own. One possible treatment option is azithromycin (500 mg p.o. q.i.d., followed by four doses of 250 mg p.o. every day). Although the long-term outlook is favorable, some people may experience hardship.
from a minor optic neuropathy that was caused by an infection.
• In POHS, systemic antifungal drugs are not required. The goals of intravitreal anti-VEGF therapy, photocoagulation, and corticosteroids are to lessen the size and effects of the macular choroidal
neovascularization.
Line Two
• It has been demonstrated that trimethoprim + sulfamethoxazole (160/800 mg p.o. b.i.d.) is an effective treatment regimen for CNS toxoplasmosis in AIDS patients. It can also be used to treat ocular toxoplasmosis in patients who cannot tolerate pyrimethamine.
• Aspirin dosages of 125–625 mg PO daily may be taken into consideration in ARN.
• When ganciclovir, foscarnet, and cidofovir are not effective in treating CMV retinitis, fomivirsen is an alternative. In the US, it is no longer accessible.
ADDITIONAL MEDICATION
Referral Issues
The treating ophthalmologist, who can assess the response to treatment, is frequently involved in management choices.
OTHER PROCEDURES AND SURGERY
Only the treatment of problems like cataract, retinal detachment, and ocular glaucoma involves surgery.
Considering the patient
First Stabilization
The majority of uveitis patients are treated as outpatients.
Requirements for Admission
Only patients with extensive ocular involvement who are monocular, socially excluded, or systemically unwell are hospitalized.
PERMANENT CARE
SUMMARY RECOMMENDATIONS
Follow-up is customized.
Monitoring of Patients
In order to control ocular inflammation, some patients with recurrent uveitis require continuous immune modulation, while others require lifelong monitoring. Even infectious uveitis, such as that caused by toxoplasmosis or herpetic keratouveitis, can reactivate ocular inflammation.
A DIET
There are no particular restrictions that are relevant to the sight.
Education of Patients
Particularly in cases of recurrent uveitis, patient education regarding early detection of signs and symptoms of ocular inflammation is crucial because timely treatment is linked to a quicker recovery and
fewer difficulties.
PROGNOSIS
The particular ailment producing chorioretinitis or uveitis determines the prognosis. 79% of patients with ocular toxoplasmosis who are monitored for more than five years will experience recurrences. Of individuals with ocular toxoplasmosis, 24% have been confirmed to have legal blindness in one or both eyes. When compared to conventional anti-CMV therapy alone, HAART has extended the duration of CMV retinitis remission by seven times. Legal blindness has decreased to roughly 6–15% every eye-year in people with CMV retinitis.
DIFFICULTIES
• Long-term use of steroids can contribute to the development of cataracts and glaucoma, which are frequent side effects of chronic ocular inflammation.
• Cystoid macular edema, which alters the normal macular architecture and reduces visual acuity, is another condition that inflammation can induce.
• Up to one-third of patients with CMV retinitis may experience rhegmatogenous retinal detachment. This also holds true for other types of necrotizing retinitis, like PORN and ARN.
0 Comments
